Cellular immunology in a historical perspective

Immunological Reviews

Volumn 185, Issue , 2002, Pages 136-158

  Good, Robert A ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

APLASTIC ANEMIA; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CLINICAL FEATURE; DIGEORGE SYNDROME; DISEASE COURSE; GRANULOMATOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HYPOPHOSPHATASIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE MICROSCOPY; MESENCHYME; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THYMUS FUNCTION; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; ALLERGY AND IMMUNOLOGY; ANIMALS; BONE MARROW TRANSPLANTATION; BURSA OF FABRICIUS; CHICKENS; CRICETINAE; DIGEORGE SYNDROME; GRANULOMATOUS DISEASE, CHRONIC; HISTORY, 20TH CENTURY; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, CELLULAR; MICE; RABBITS; THYMOMA;

EID: 0036630692     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.18513.x     Document Type: Review

References (146)

1. A clinical and experimental study of agammaglobulinemia
2. Thymic tumor and acquired agammaglobulinemia: A clinical and experimental study of the immune response
3. Thymoma
4. Thymoma, immunologic deficiencies and hematological abnormalities
5. Agammaglobulinemia
6. Absence of serum gammaglobulins
7. Agammaglobulinemia
8. Multiple serum protein deficiencies in congenital and acquired agammaglobulinemia
9. Disturbances in gamma globulin synthesis as 'experiments of nature'
10. Agammaglobulinemia: A provocative experiment of nature
11. Connective tissue diseases and certain serum protein components in patients with agammaglobulinemia
12. The Minnesota scene: A crucial portal of entry to modern cellular immunology
13. Studies on agammaglobulinemia. II. Failure of plasma cell formation in the bone marrow and lymph nodes of patients with agammaglobulinemia
14. Absence of plasma cells from bone marrow and lymph nodes following antigenic stimulation in patients with agammaglobulinemia
15. Discussions on new concept of cellular basis of immunity [following presentation by MD Cooper]. Peterson and Good
16. Congenital absence of the thymus and its immunologic consequences: Concurrence with congenital hypoparathyroidism
17. Familiare lymphopenie mit agammaglobulinamie und schwerer moniliasis
18. Hereditare lymphoplasmocytare dysgenesie ('Alymphocytose mit Agammaglobulinamie')
19. Essentialle lymphocytophthise. Ein neues krankheitsbild aus der sauglingspathologie
20. Immunologic function of the thymus
21. Effect of neonatal thymectomy on the immunological responsiveness of the mouse
22. The role of the thymus in transplantation immunity. I. The role of the lymphoid system in homotransplantation reactions
23. Effect of thymic ablation and replacement
24. Role of thymus in development of the immune response
25. Skin homograft survival in thymectomized mice
26. Effect of thymectomy on development of immunological competence in mice
27. Acceptance of tumor homografts by thymectomized mice
28. Failure of spleen cells from thymectomized mice to induce graft versus host reactions
29. Further studies of suppression of the homograft reaction by thymectomy in the mouse
30. Studies of immunologic characteristics of lymphoid cells from thymectomized mice
31. The role of the thymus in the development of immunologic capacity in rabbits and mice
32. Selective depletion of lymphoid tissue by cyclophosphamide
33. Thymus-dependent areas in the lymphoid organs of neonatally thymectomized mice
34. Experimental and clinical models of immune deficiency and reconstitution of immunologic capacity
35. Role of the thymus in immune reactions in rats. I. The immunologic response to bovine serum albumin (antibody formation, Arthus reactivity, and delayed hypersensitivity) in rats thymectomized or splenctomized at various times after birth
36. The role of the thymus in immune reactions in rats
37. Effect of thymectomy and bursectomy on the survival of skin homografts in chickens
38. The bursa of Fabricius and antibody production
39. The functions of the thymus system and the bursa system in the chicken
40. Further studies on the role of the bursa of Fabricius in antibody production
41. The immunological role of different lymphoid organs in the chicken. I. Dissociation of immunological responsiveness
42. Immunologic studies on hormonally bursectomized and surgically thymectomized chickens: Disassociation of immunologic responsiveness
43. Reduced antibody response in thymectomized rabbits
44. The role of the thymus in development of immunologic capacity in rabbits and mice
45. The function of the thymus in the golden hamster
46. Intestinal crypt lesions in neonatally antibody thymectomized hamsters
47. Delineation of the thymic and bursal lymphoid systems in the chicken
48. Role of the thymus and the bursa of Fabricius in immune reactions in chickens. I. Changes in lymphoid tissues of chickens surgically thymectomized at hatching
49. The two-component concept of the lymphoid system
50. Experimental arrest and induction of lymphoid development in intestinal lymphoepethelial tissues of rabbits
51. Immunodeficiency in developmental perspective
52. Thymus: An essential factor in lymphoid repopulation
53. Immunological deficiency diseases of man - Relationships to disturbances of germinal center formation
54. The pathogenesis of immunologic deficiency diseases
55. Effect of thymectomy on development of leukemia in C3H mice inoculated with leukemic 'passage' virus
56. The influence of thymectomy on the incidence of carcinogen-induced leukemia in strain DBA mice
57. Lymphohomagenesis in relation to germinal centers and to the bursa of Fabricius
58. Relationships among visceral lymphomatosis bursa of Fabricius and bursa-dependent lymphoid tissue of the chicken
59. Reversal of post-thymectomy wasting in mice with immunocompetent cells: Influence of histocompatibility differences
60. Role of the thymus in immune reactions in rats. III. Changes in the lymphoid organs of thymectomized rats
61. Suppression of antibody forming capacity with thymectomy in the mouse
62. The immunological deficiency diseases of man: Consideration of some questions asked by these patients with an attempt at classification
63. La buorse de Fabricius et les organes lympho-epitheliaux
64. Appendix of the rabbit: A homologue of the bursa in the chicken?
65. Role of the appendix in development of immunologic capacity
66. Relative contributions of the thymus and the bursa of Fabricius to the maturation of the lymphoreticular system and immunological potential in the chicken
67. The development of lymphoid systems: Immune response and radiation sensitivity in lower vertebrates
68. The phylogenetic occurrence of lymphocytes within the gut epithelium
69. A mammalian equivalent of he avian bursa of Fabricius
70. Production of an antibody deficiency syndrome in rabbits by neonatal removal of organized intestinal lymphoid tissues
71. B cell differentiation
72. Generating the antibody repertoire in rabbit
73. Antibody-producing capacity of adult chicken spleen cells in newly hatched chicks: A study of sources of variation in a homologous cell transfer system
74. The developmental biology of lymphoid tissue in the rabbit, consideration of the role of thymus and appendix
75. Development and function of the immunoglobulin producing system. I. Effect of bursectomy at different stages of development on germinal centers, plasma cells, immunoglobulins and antibody production
76. Relationship of the bursa of Fabricius to immunologic responsiveness and homograft immunity in the chicken
77. Gammaglobulin production and antibody synthesis in chickens bursectomized as embryos
78. Cellular immune competence of spleen bursa and thymus cells
79. Role of the thymus in humoral immunity: Observations in complete or partial congenital absence of the thymus
80. The spectrum of the DiGeorge syndrome
81. DiGeorge syndrome: A chromosome 22q11.2 deletion syndrome
82. Foetal thymus transplant in a case of DiGeorge syndrome
83. Implantation of a fetal thymus, restoring immunological competence in a patient with thymus aplasia (DiGeorge's Syndrome)
84. Morphological and functional studies of fetal thymus transplants in mice
85. Development of T cell function after postnatal thymic transplantation for DiGeorge syndrome
86. Transplantation of the thymus tissue in complete DiGeorge syndrome
87. T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool
88. A fatal granulomatosus of childhood: The clinical study of a new syndrome
89. A fatal granulomatous disease of childhood: The clinical, pathological and laboratory features of a new syndrome
90. Chronic granulomatous disease in females: A deficiency of leukocyte glutathione peroxidase
91. The metabolic pattern and phagocytic function of leukocytes from children with chronic granulomatous diseases
92. Fatal granulomatous disease: A genetic defect of phagocytic function
93. Fatal (chronic) granulomatous disease of childhood: A hereditary defect of leukocyte function
94. Chronic granulomatous disease
95. Defective polymorphonuclear-leukocyte function and chronic granulomatous disease in two female children
96. Chronic granulomatous disease in three female siblings
97. Nonmyeloablative stem cell transplantation cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
98. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow
99. Immunological reconstitution of sex-linked lymphopenic immunological deficiency
100. Successful marrow transplantation for correction of immunological deficit in lymphopenic agammaglobulinemia and treatment of immunologically induced pancytopenia
101. Immunologic reconstitution: The achievement and its meaning
102. Progress toward a cellular engineering. [Lasker Award Lecture]
103. Treatment of lymphopenic hypogammaglobulinemia and bone marrow aplasia by transplantation of allogeneic marrow
104. Bone marrow transplantation: Correction of immune deficit in lymphopenic immunologic deficiency and correction of an immunologically induced pancytopenia
105. Follow-up of correction of severe dual system immunodeficiency with bone marrow transplantation
106. Bone marrow transplantation cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia
107. Marrow transplantation and stem cell transplantation in 1996 - The developmental perspective
108. Organization and development of the immune system: Relation to its reconstruction
109. Rationale for bone marrow transplantation in the treatment of autoimmune diseases
110. The prospects for BMT - From mouse to human
111. The role of hematopoietic stem cell transplantation in autoimmune glomerulonephritis
112. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells
113. Treatment of autoimmune diseases by hematopoietic stem cell transplantation
114. Prevention of type I diabetes in non-obese diabetic mice by allogeneic bone marrow transplantation
115. Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue
116. Autoimmune thyroiditis after bone marrow transplantation
117. (NZW x BXSB) F1 mouse, a new model of idiopathic thrombocytopenic purpura
118. 1 mice by haploidentical bone marrow transplantation: Possible role for anticardiolipin autoantibodies
119. Prevention of coronary vascular disease by transplantation of T cell depleted bone marrow and hematopoietic stem cell preparation in autoimmune-prone W/BF1 mice
120. Successful prevention of autoimmune disease by transplantation of adequate number of fully allogeneic hematopoietic stem cells
121. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation
122. Prevention of autoimmune inflammatory polyarthritis in male New Zealand Black/Kn mice by transplantation of bone marrow cells plus bone (stromal cells)
123. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: Complete prevention of recurrence of autoimmune diseases in MRL/lpr mice by transplantation of bone marrow plus bone (stromal cells) from the same donor
124. Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation
125. Treatment of autoimmune disease in BXSB mice by mixed bone marrow transplantation
126. Mixed peripheral blood stem cell transplantation for autoimmune disease in BXSB/Mpj Mice
127. (NZW x BXSB) F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction
128. Allogeneic bone marrow transplantation using stem cells fractionated by lectins. VI. In vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin
129. Enrichment for CFU-C from murine and human bone marrow soybean agglutinin
130. Transplantation for acute leukemia with HLA-A and -B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells
131. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation
132. CD40 ligand and the hyper-IgM syndrome
133. Immunologic reconstitution following bone marrow transplantation for X-linkedhyper IgM syndrome
134. Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria
135. Mannose-binding lectin: The pluripotent molecule of the innate immune system
136. Serum lectin with known structure activates complement through the classical pathway
137. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding protein
138. Susceptibility to severe infections in a family due to inherited deficiency of mannan-binding lectin
139. Successful transplantation to correct a metabolic bone disease (infantile hypophosphatasia) using bone fragments plus cultured osteoblasts with T cell depleted mismatched bone marrow without lymphohematopoietic engraftment
140. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
141. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination
142. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells
143. Gene therapy of human severe combinedimmunodeficiency (SCID)-XI disease
144. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
145. Gene therapy of lymphoid primary immunodeficiencies